查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1990460

传统髋关节螺丝市场：2026-2032年全球市场预测（按产品类型、材料、手术入路、应用、最终用户和分销管道划分）

Conventional Hip Screws Market by Product Type, Material, Surgical Approach, Application, End User, Distribution Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 184 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2025 年传统髋螺丝市场价值为 4.466 亿美元，预计到 2026 年将成长至 4.6995 亿美元，复合年增长率为 5.85%，到 2032 年将达到 6.6495 亿美元。

主要市场统计数据
基准年 2025 4.466亿美元
预计年份：2026年 4.6995亿美元
预测年份：2032年 6.6495亿美元
复合年增长率 (%) 5.85%

对现代常规髋螺钉在外科手术实践中的临床、操作和监管基础进行全面概述。

本执行摘要详细分析了传统髋螺钉，整合了影响医院采购和医疗设备应用的临床趋势、供应链发展和产品设计考量。引言部分概述了影响医疗医疗设备选择的临床需求，包括骨折类型处理、固定稳定性要求以及外科医生基于解剖多样性和患者合併症情况的偏好。透过阐明传统髋螺钉在整形外科医学中的现状，本概要解释了医疗设备设计、材料选择和手术入路之间的相互联繫，以及它们如何影响术中说明和术后结果。

技术进步、外科手术技术变革和供应链韧性如何重新定义髋关节植入的竞争格局和临床应用？

传统髋关节螺钉的市场格局正因技术进步、外科手术技术的提升以及相关人员期望的改变而重塑，这些变革正在影响采购决策和产品开发重点。植入冶金和生物可吸收复合材料的进步促使人们重新评估长期以来材料选择上的权衡取舍，而锁定介面和套管技术的改进则使外科医生能够在减少软组织损伤的同时，采用更精准的固定策略。

为因应 2025 年实施的关税措施，政策主导的采购审查和供应链调整正在推进，植入相关人员的供应商、定价结构和业务永续营运正在重组。

2025年关税的引入和贸易政策的变化带来了新的变数，将影响整形外科植入的製造策略、分销经济效益和临床采购实践。这些政策转变迫使製造商重新评估筹资策略，一些製造商透过供应商多元化和生产线重组来降低关税风险。因此，整个医疗保健系统的采购团队都在日益关注总到岸成本以及集中采购模式与在地化采购模式之间的权衡取舍。

透过对临床应用案例、医疗保健环境和产品架构进行策略性細項分析，确保医疗设备产品与采购重点的精准匹配。

对市场区隔的精准理解揭示了临床需求、采购优先顺序和产品设计之间的交集，从而明确了在应用、医疗环境、分销模式、材料、手术方法和产品架构等方面的策略定位。单独考虑应用时，产品环境可分为重组手术和创伤手术，二者分别对应不同的性能要求和器械需求。重组手术通常优先考虑长期固定和与人工关节重建的兼容性，而创伤手术则优先考虑快速稳定和在紧急情况下易于植入。

区域商业化需求和临床应用模式指导着全球整形外科市场的分销策略和外科培训重点。

区域趋势为供应链发展、临床医生培训投资和监管合规提供了至关重要的背景信息，指明了製造商和经销商应将商业化和营运资源集中于哪些领域。在美洲，医疗保健格局的特点是：大规模创伤中心网络广泛分布，择期整形外科手术中微创技术应用普遍，以及采购环境成熟，强调临床疗效和治疗总成本的证据。这种环境支持植入和服务模式，从而确保外科医生能够快速采用这些模式，并确保供应的可靠性和可预测性。

透过创新、临床证据和供应弹性实现竞争定位，正在影响供应商的选择和传统髋关节螺钉系统的采用。

医疗设备製造商和供应商之间的竞争格局取决于技术差异化、临床证据的累积以及提供全面服务包的能力，这些服务包能够降低手术团队采用产品的门槛。主要企业正投资于模组化系统和整合器械解决方案，以促进微创植入；而其他企业则强调产品组合的广度，以支持重组外科和创伤适应症等各种不同的病例组合。製造商和分销商之间的策略伙伴关係仍然是扩大市场渗透率的关键，尤其是在提供客製化培训和术中植入交付计划以支持外科医生学习曲线的情况下。

医疗设备製造商和供应商可采取切实可行的策略措施，以加速器材普及、增强供应连续性，并使商业化与临床工作流程保持一致。

产业领导企业应采取多管齐下的策略，将产品开发、商业策略和临床医生协作结合，以确保产品的永续应用和营运效率。优先事项应包括投资于以临床医生为中心的设计改进，以降低手术复杂性，并兼顾微创和开放式手术。这将扩大产品在所有创伤和重组适应症中的适用性。器械人体工学和手术专用工具包的配套投资将缩短学习曲线，减少手术时间，从而促进产品在高流量创伤中心和门诊手术中心的应用。

为了确保获得可靠和实用的见解，我们采用多层次的调查方法，结合与专家的直接对话、证据整合和跨部门检验。

本调查方法采用多层次整合策略，旨在产生可靠且可操作的洞见，并透过交叉检验多个资料流来验证研究结果并减少偏差。关键的定性资料包括对骨科医生、采购经理和分销合作伙伴的结构化访谈，从而直接观点临床偏好、采购决策标准和物流限制。此外，也对医疗器材层面的技术审查和监管申报文件进行评估，从而深入了解产品设计选择和上市后监测的考量。

在不断发展的整形外科医学领域，临床、商业性和营运要求的整合决定了植入开发商和医疗保健采购商的成功。

总之，在临床创新、手术技术现代化和外部经济因素的复杂交互作用下，传统髋关节螺钉的市场格局正在改变。人们对器械性能的期望不再局限于即时固定，而是包括能够提高外科医生效率、简化器械操作以及帮助医疗机构实现品质和成本目标的可验证疗效。这些变化为製造商创造了新的机会，他们可以将技术改进与有意义的证据和可扩展的商业模式相结合，从而满足创伤中心、医院、门诊手术中心和专科诊所的多样化需求。

目录

第一章：序言

第二章：调查方法

  • 调查设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查的前提
  • 研究限制

第三章执行摘要

  • 首席主管观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 工业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会映射
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章 传统髋关节螺丝市场：依产品类型划分

  • 中空髋关节螺丝
  • 动态髋关节螺丝系统
  • 锁定式髋螺钉
  • 非中空、非锁定式髋螺钉

第九章：传统髋螺钉市场：依材料分类

  • 生物可吸收
  • 防锈的
  • 钛

第十章 传统髋关节螺丝市场：依手术入路划分

  • 微创
  • 打开

第十一章 传统髋关节螺丝市场：依应用领域划分

  • 重组手术
  • 创伤

第十二章 传统髋螺丝市场：依最终用户划分

  • 门诊手术中心
  • 医院
  • 整形外科诊所
  • 创伤中心

第十三章：传统髋螺丝市场：依通路划分

  • 直销
  • 销售代理

第十四章 传统髋关节螺丝市场：依地区划分

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十五章 传统髋螺丝市场：依组别划分

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十六章 传统髋螺丝市场：依国家划分

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十七章：美国传统髋关节螺丝市场

第十八章：中国传统髋关节螺丝市场

第十九章 竞争情势

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • Acumed LLC
  • Altius Healthcare Ltd.
  • Arthrex, Inc.
  • B. Braun Melsungen AG
  • BioTek Instruments, Inc.
  • CONMED Corporation
  • DJO Global, Inc.
  • Exactech, Inc.
  • FH Orthopedics
  • Globus Medical, Inc.
  • Integra LifeSciences Corporation
  • KLS Martin Group
  • Life Spine, Inc.
  • Limacorporate SpA
  • Medtronic plc
  • MicroPort Scientific Corporation
  • NuVasive, Inc.
  • Orthofix Medical Inc.
  • Smith & Nephew plc
  • Stryker Corporation
  • Waston Medical Corporation
  • Wright Medical Group NV
  • Zimmer Biomet Holdings, Inc.
Product Code: MRR-3A68B83977E6

The Conventional Hip Screws Market was valued at USD 446.60 million in 2025 and is projected to grow to USD 469.95 million in 2026, with a CAGR of 5.85%, reaching USD 664.95 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 446.60 million
Estimated Year [2026] USD 469.95 million
Forecast Year [2032] USD 664.95 million
CAGR (%) 5.85%

Comprehensive orientation to clinical, operational, and regulatory fundamentals that define contemporary conventional hip screw utilization across surgical practice

This executive summary introduces a rigorous analysis of conventional hip screws, synthesizing clinical trends, supply chain dynamics, and product architecture considerations that influence hospital procurement and device adoption. The introduction frames the clinical imperatives driving device selection, including fracture pattern management, fixation stability requirements, and surgeon preferences linked to anatomical variability and patient comorbidity profiles. By contextualizing conventional hip screws within current orthopaedic practice, the narrative clarifies how device design, material choice, and surgical approach intersect to affect intraoperative decision-making and postoperative outcomes.

Transitioning from clinical need to commercial context, the introduction also outlines the technological lineage of hip screw devices and the contemporary focus on minimally invasive techniques, locking mechanisms, and material innovations intended to optimize healing biomechanics. Moreover, regulatory and reimbursement environments continue to shape product lifecycle strategies, with post-market surveillance and real-world evidence becoming increasingly central to device differentiation. This section establishes the foundational concepts and evaluation criteria that underpin subsequent analysis, ensuring readers possess the clinical, operational, and regulatory perspective needed to interpret segmentation, regional patterns, and implications for manufacturing and distribution partners.

Finally, the introduction sets expectations for the report's methodology and the granularity of insights, clarifying that the emphasis is on actionable intelligence for stakeholders ranging from clinical adoption committees to commercial strategy teams. It positions the report as a practical instrument to refine product portfolios, inform hospital purchase protocols, and guide engagement with surgeons and procurement officers in diverse care settings.

How technological advances, procedural shifts, and supply chain resilience are collectively redefining competitive dynamics and clinical adoption of hip screw implants

The landscape for conventional hip screws is being reshaped by a confluence of technological refinement, procedural evolution, and shifting stakeholder expectations, producing transformative shifts that will influence procurement decisions and product development priorities. Advances in implant metallurgy and bioabsorbable composites are prompting reevaluation of long-standing material trade-offs, while improvements in locking interfaces and cannulation techniques are enabling surgeons to pursue more precise fixation strategies with reduced soft-tissue disruption.

Concurrently, procedural trends toward minimally invasive approaches are altering instrumentation requirements and operating room workflows, amplifying demand for devices and kits that simplify percutaneous placement while maintaining biomechanical integrity. At the same time, supply chain resilience and nearshoring considerations are prompting manufacturers and distributors to reassess distribution footprints and contractual frameworks, seeking to reduce lead times and ensure sterile implant availability for high-acuity trauma caseloads.

Clinically, heightened emphasis on patient-reported outcomes and the integration of data from registries and electronic health records are enabling more granular comparative assessments of implant performance over the care continuum. These data-driven insights are reinforcing preferences for implants that demonstrably reduce reoperation rates and support rehabilitation protocols. From a commercial vantage point, the interplay of these trends fosters opportunities for device differentiation through modular implant systems, procedure-specific instrumentation, and enhanced training programs designed to accelerate surgeon competency with new approaches. Taken together, these shifts create a dynamic environment in which agility and evidence-based positioning are essential for sustained relevance.

Policy-driven procurement recalibration and supply chain adaptation in response to 2025 tariffs reshaping sourcing, pricing structures, and operational continuity for implant stakeholders

The implementation of tariffs and trade policy changes in 2025 has introduced new variables that reverberate through manufacturing strategies, distribution economics, and clinical procurement practices for orthopaedic implants. These policy shifts have prompted manufacturers to reassess sourcing strategies for raw materials and subcomponents, particularly for stainless steel and titanium alloys, leading some producers to diversify suppliers and reconfigure production lines to mitigate tariff exposure. As a result, procurement teams across health systems are increasingly scrutinizing total landed costs and the trade-offs associated with centralized versus localized sourcing models.

Beyond supplier reconfiguration, the tariff environment has stimulated more active collaboration between manufacturers and distributors to explore pricing structures, consignment options, and value-based contracting to preserve access to essential implants in high-volume trauma centers and reconstructive programs. Hospitals and ambulatory surgical centers are responding by strengthening strategic relationships with trusted suppliers and by adopting more rigorous purchase agreement terms that account for tariff-driven volatility. This environment has also spurred conversations about inventory management, with greater attention to buffer stock strategies and working capital implications for smaller orthopedic clinics and ambulatory surgical centers.

From an innovation perspective, some manufacturers are revisiting material substitutions and manufacturing efficiencies to contain cost impacts while preserving clinical performance. This realignment underscores the importance of flexible commercial models and proactive policy monitoring by stakeholders across the implant value chain, so that clinical continuity and patient care pathways remain robust despite evolving trade constraints.

Strategic segmentation analysis aligning clinical use cases, care settings, and product architectures to enable precise alignment of device offerings and procurement priorities

A nuanced understanding of segmentation illuminates where clinical demand, procurement priorities, and product design intersect, providing clarity for strategic positioning across applications, care settings, distribution models, materials, surgical approaches, and product architectures. When examined by application, the product landscape bifurcates between reconstructive surgery and trauma, each driving distinct performance profiles and instrumentation needs; reconstructive procedures often emphasize long-term fixation and compatibility with arthroplasty pathways, whereas trauma applications prioritize rapid stability and ease of insertion in emergent contexts.

End user segmentation further differentiates demand patterns across ambulatory surgical centers, hospitals, orthopedic clinics, and trauma centers, reflecting variation in case complexity, inventory capacity, and procedural throughput. Distribution channel dynamics break down into direct sales and distributors, with direct relationships favoring tailored training and bundled services, while distributor networks offer reach and logistical scalability. Material segmentation-spanning bioabsorbable options, stainless steel, and titanium-shapes both clinical handling and regulatory pathways, and influences sterilization practices, imaging artifact considerations, and long-term biocompatibility discussions.

Surgical approach segmentation contrasts minimally invasive and open techniques, driving divergent instrument sets and implant geometries that can alter OR time and postoperative recovery trajectories. Product-type segmentation captures the diversity of device families, encompassing cannulated hip screws, dynamic hip screw systems, locking hip screws, and non-cannulated nonlocking hip screws. Within these families there are important sub-classifications: cannulated hip screws are distinguished by screw diameter, commonly categorized across diameters such as 6.5 mm, 7.3 mm, and 8.0 mm; dynamic hip screw systems differentiate by plate type, including single-barrel and double-barrel configurations; locking hip screws are defined by screw type, such as locking cannulated and locking head variants; and non-cannulated nonlocking hip screws are segmented by screw size into large, medium, and small. Collectively, these segmentation lenses permit precise alignment of product offerings with clinical protocols and institutional purchasing strategies, enabling manufacturers and providers to optimize inventories and training programs according to procedural mix and surgeon preference.

Regional commercialization imperatives and clinical adoption patterns guiding distribution strategies and surgeon training priorities across global orthopaedic landscapes

Regional dynamics impart important context for supply chain configuration, clinician training investments, and regulatory navigation, informing where manufacturers and distributors should concentrate commercialization and operational resources. In the Americas, the healthcare environment is characterized by a broad network of high-volume trauma centers, widespread adoption of minimally invasive techniques in elective orthopedics, and a sophisticated procurement landscape that values evidence of clinical outcomes and total cost of care. These conditions favor implants and service models that support rapid surgeon adoption and predictable supply reliability.

Across Europe, the Middle East & Africa, regulatory heterogeneity and diverse hospital funding mechanisms necessitate adaptive market-entry strategies and flexible distribution partnerships. Nations within this region may prioritize different materials or procedural approaches based on reimbursement frameworks and surgical training norms, creating opportunities for targeted clinical education and localized inventory strategies. Meanwhile, Asia-Pacific presents a heterogeneous mix of high-growth urban centers with growing orthopedic procedural volumes alongside markets where access and infrastructure constraints influence device selection and distribution. Rapid expansion of ambulatory surgical centers and increasing investment in trauma care capacity in several Asia-Pacific countries create demand for implants that balance cost-effectiveness with reliable clinical performance.

Taken together, these regional distinctions underscore the importance of tailoring commercialization approaches to local regulatory environments, clinical practice patterns, and supply chain realities. Manufacturers that align distribution models, training programs, and product portfolios to regional priorities can better support surgeons and procurement teams in addressing both routine and complex fixation needs.

Competitive positioning through innovation, clinical evidence, and supply resilience shaping vendor preference and adoption of conventional hip screw systems

Competitive dynamics among device manufacturers and suppliers are shaped by technological differentiation, clinical evidence generation, and the ability to deliver comprehensive service packages that reduce adoption friction for surgical teams. Leading firms have invested in modular systems and integrated instrumentation solutions that facilitate minimally invasive placement, while others emphasize the breadth of their portfolio to support diverse case mixes across reconstructive and trauma indications. Strategic partnerships between manufacturers and distributors remain central to expanding reach, particularly when tailored training and implants-in-theatre programs are offered to support surgeon learning curves.

Innovation pathways are increasingly defined by iterative improvements in implant locking mechanisms, cannulation geometry, and plate design, with several companies also investing in enhanced packaging and kit optimization to streamline operating room logistics. Clinical evidence and registry data play a growing role in competitive positioning, as hospitals and procurement groups seek implants backed by robust real-world performance metrics. At the same time, nimble smaller manufacturers are finding opportunities by targeting niche clinical needs or offering specialized instrumentation that reduces procedural complexity.

Supply-side resilience is another competitive lever, with companies that can demonstrate reliable lead times, diversified manufacturing footprints, and responsive customer support gaining preference among institutional buyers. Additionally, firms that proactively engage clinicians through training programs, simulation, and outcomes collaboration are better positioned to influence long-term product selection and to integrate their implants into standardized care pathways.

Practical strategic moves for manufacturers and providers to accelerate device adoption, strengthen supply continuity, and align commercialization with clinical workflows

Industry leaders should pursue a multi-pronged approach that aligns product development, commercial strategy, and clinician engagement to secure sustainable adoption and operational efficiency. Priority actions include investing in clinician-centric design enhancements that reduce procedural complexity and accommodate both minimally invasive and open approaches, thereby expanding appeal across trauma and reconstructive indications. Complementary investments in instrumentation ergonomics and procedure-specific kits can shorten learning curves and reduce operating room time, supporting adoption among high-volume trauma centers and ambulatory surgical settings.

From a commercial perspective, developing flexible distribution arrangements that blend direct sales for high-touch accounts with distributor partnerships for broader geographic reach can improve market access while preserving opportunities for clinical training and bundled solutions. Manufacturers should also consider targeted regional strategies that respond to regulatory nuances and procurement modalities, prioritizing supply chain resilience in regions where tariff exposure or logistical constraints present risks. In parallel, building a compelling value story through clinical evidence, registry participation, and surgeon outcomes partnerships will strengthen dialogue with hospital committees and procurement teams.

Finally, collaboration between manufacturers, distributors, and clinical leaders to design inventory models, consignment programs, and educational initiatives can reduce adoption barriers for smaller orthopedic clinics and ambulatory surgical centers. Emphasizing transparency in total acquisition costs, operational benefits, and patient-centered outcomes will better equip decision-makers to evaluate device options in a resource-constrained environment.

Layered methodological framework combining primary expert engagement, evidence synthesis, and cross-functional validation to ensure credible actionable insights

The research methodology integrates a layered approach designed to produce robust, actionable insights while triangulating across multiple data streams to verify findings and reduce bias. Primary qualitative inputs include structured interviews with orthopedic surgeons, procurement leaders, and distribution partners, offering direct perspectives on clinical preferences, purchasing decision criteria, and logistical constraints. These interviews are supplemented with device-level technical reviews and an assessment of regulatory filings to contextualize product design choices and post-market surveillance considerations.

Secondary research was conducted by reviewing peer-reviewed clinical literature, procedural guidelines, and public regulatory documentation to ground clinical assertions in evidence. In addition, supply chain and policy analyses were performed to evaluate the operational implications of tariffs, trade policy changes, and manufacturing footprint strategies. Synthesis of these inputs was organized around the segmentation framework covering application, end user, distribution channel, material, surgical approach, and product type, enabling cross-cutting analysis of how clinical needs and commercial realities intersect.

Analytical rigor was maintained through iterative validation workshops with clinical and industry experts, ensuring that interpretations were consistent with frontline practice. Where appropriate, sensitivity checks were applied to qualitative findings to surface alternative explanations and to highlight areas requiring additional data collection or targeted field research. The combination of primary stakeholder engagement, evidence review, and cross-functional validation supports the credibility and practical utility of the conclusions and recommendations presented in this report.

Synthesis of clinical, commercial, and operational imperatives that define success for implant developers and institutional buyers in evolving orthopaedic care

In conclusion, the conventional hip screw landscape is evolving under the combined influence of clinical innovation, procedural modernisation, and external economic drivers. Device performance expectations now extend beyond immediate fixation to encompass surgeon ergonomics, streamlined instrumentation, and demonstrable outcomes that support institutional quality and cost objectives. These changes create opportunities for manufacturers that can marry technical improvements with meaningful evidence and scalable commercial models that address the diverse needs of trauma centers, hospitals, ambulatory surgical centers, and specialty clinics.

At the same time, supply chain and policy developments underscore the necessity of resilient sourcing strategies and flexible distribution architectures to maintain clinical continuity. Regional dynamics further emphasize the need to tailor product portfolios and engagement programs to local regulations, training ecosystems, and procurement modalities. For clinical leaders and purchasing decision-makers, the pathway forward involves prioritizing implants that align with procedural mixes, surgeon preferences, and institutional capacity to support inventory and training investments.

Ultimately, organizations that integrate clinician-focused design, evidence-driven value propositions, and adaptive commercial approaches will be best positioned to meet evolving clinical demands while safeguarding operational resilience. This report serves as a practical guide for stakeholders seeking to refine product strategies, strengthen supply relationships, and optimize clinical adoption of conventional hip screw systems.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Conventional Hip Screws Market, by Product Type

  • 8.1. Cannulated Hip Screws
  • 8.2. Dynamic Hip Screw Systems
  • 8.3. Locking Hip Screws
  • 8.4. Non-Cannulated Nonlocking Hip Screws

9. Conventional Hip Screws Market, by Material

  • 9.1. Bioabsorbable
  • 9.2. Stainless Steel
  • 9.3. Titanium

10. Conventional Hip Screws Market, by Surgical Approach

  • 10.1. Minimally Invasive
  • 10.2. Open

11. Conventional Hip Screws Market, by Application

  • 11.1. Reconstructive Surgery
  • 11.2. Trauma

12. Conventional Hip Screws Market, by End User

  • 12.1. Ambulatory Surgical Centers
  • 12.2. Hospitals
  • 12.3. Orthopedic Clinics
  • 12.4. Trauma Centers

13. Conventional Hip Screws Market, by Distribution Channel

  • 13.1. Direct Sales
  • 13.2. Distributors

14. Conventional Hip Screws Market, by Region

  • 14.1. Americas
    • 14.1.1. North America
    • 14.1.2. Latin America
  • 14.2. Europe, Middle East & Africa
    • 14.2.1. Europe
    • 14.2.2. Middle East
    • 14.2.3. Africa
  • 14.3. Asia-Pacific

15. Conventional Hip Screws Market, by Group

  • 15.1. ASEAN
  • 15.2. GCC
  • 15.3. European Union
  • 15.4. BRICS
  • 15.5. G7
  • 15.6. NATO

16. Conventional Hip Screws Market, by Country

  • 16.1. United States
  • 16.2. Canada
  • 16.3. Mexico
  • 16.4. Brazil
  • 16.5. United Kingdom
  • 16.6. Germany
  • 16.7. France
  • 16.8. Russia
  • 16.9. Italy
  • 16.10. Spain
  • 16.11. China
  • 16.12. India
  • 16.13. Japan
  • 16.14. Australia
  • 16.15. South Korea

17. United States Conventional Hip Screws Market

18. China Conventional Hip Screws Market

19. Competitive Landscape

  • 19.1. Market Concentration Analysis, 2025
    • 19.1.1. Concentration Ratio (CR)
    • 19.1.2. Herfindahl Hirschman Index (HHI)
  • 19.2. Recent Developments & Impact Analysis, 2025
  • 19.3. Product Portfolio Analysis, 2025
  • 19.4. Benchmarking Analysis, 2025
  • 19.5. Acumed LLC
  • 19.6. Altius Healthcare Ltd.
  • 19.7. Arthrex, Inc.
  • 19.8. B. Braun Melsungen AG
  • 19.9. BioTek Instruments, Inc.
  • 19.10. CONMED Corporation
  • 19.11. DJO Global, Inc.
  • 19.12. Exactech, Inc.
  • 19.13. FH Orthopedics
  • 19.14. Globus Medical, Inc.
  • 19.15. Integra LifeSciences Corporation
  • 19.16. KLS Martin Group
  • 19.17. Life Spine, Inc.
  • 19.18. Limacorporate S.p.A.
  • 19.19. Medtronic plc
  • 19.20. MicroPort Scientific Corporation
  • 19.21. NuVasive, Inc.
  • 19.22. Orthofix Medical Inc.
  • 19.23. Smith & Nephew plc
  • 19.24. Stryker Corporation
  • 19.25. Waston Medical Corporation
  • 19.26. Wright Medical Group N.V.
  • 19.27. Zimmer Biomet Holdings, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL CONVENTIONAL HIP SCREWS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL CONVENTIONAL HIP SCREWS MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL CONVENTIONAL HIP SCREWS MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL CONVENTIONAL HIP SCREWS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL CONVENTIONAL HIP SCREWS MARKET SIZE, BY MATERIAL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL CONVENTIONAL HIP SCREWS MARKET SIZE, BY SURGICAL APPROACH, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL CONVENTIONAL HIP SCREWS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL CONVENTIONAL HIP SCREWS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL CONVENTIONAL HIP SCREWS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL CONVENTIONAL HIP SCREWS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL CONVENTIONAL HIP SCREWS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL CONVENTIONAL HIP SCREWS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 13. UNITED STATES CONVENTIONAL HIP SCREWS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 14. CHINA CONVENTIONAL HIP SCREWS MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL CONVENTIONAL HIP SCREWS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL CONVENTIONAL HIP SCREWS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL CONVENTIONAL HIP SCREWS MARKET SIZE, BY CANNULATED HIP SCREWS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL CONVENTIONAL HIP SCREWS MARKET SIZE, BY CANNULATED HIP SCREWS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL CONVENTIONAL HIP SCREWS MARKET SIZE, BY CANNULATED HIP SCREWS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL CONVENTIONAL HIP SCREWS MARKET SIZE, BY DYNAMIC HIP SCREW SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL CONVENTIONAL HIP SCREWS MARKET SIZE, BY DYNAMIC HIP SCREW SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL CONVENTIONAL HIP SCREWS MARKET SIZE, BY DYNAMIC HIP SCREW SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL CONVENTIONAL HIP SCREWS MARKET SIZE, BY LOCKING HIP SCREWS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL CONVENTIONAL HIP SCREWS MARKET SIZE, BY LOCKING HIP SCREWS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL CONVENTIONAL HIP SCREWS MARKET SIZE, BY LOCKING HIP SCREWS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL CONVENTIONAL HIP SCREWS MARKET SIZE, BY NON-CANNULATED NONLOCKING HIP SCREWS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL CONVENTIONAL HIP SCREWS MARKET SIZE, BY NON-CANNULATED NONLOCKING HIP SCREWS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL CONVENTIONAL HIP SCREWS MARKET SIZE, BY NON-CANNULATED NONLOCKING HIP SCREWS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL CONVENTIONAL HIP SCREWS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL CONVENTIONAL HIP SCREWS MARKET SIZE, BY BIOABSORBABLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL CONVENTIONAL HIP SCREWS MARKET SIZE, BY BIOABSORBABLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL CONVENTIONAL HIP SCREWS MARKET SIZE, BY BIOABSORBABLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL CONVENTIONAL HIP SCREWS MARKET SIZE, BY STAINLESS STEEL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL CONVENTIONAL HIP SCREWS MARKET SIZE, BY STAINLESS STEEL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL CONVENTIONAL HIP SCREWS MARKET SIZE, BY STAINLESS STEEL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL CONVENTIONAL HIP SCREWS MARKET SIZE, BY TITANIUM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL CONVENTIONAL HIP SCREWS MARKET SIZE, BY TITANIUM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL CONVENTIONAL HIP SCREWS MARKET SIZE, BY TITANIUM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL CONVENTIONAL HIP SCREWS MARKET SIZE, BY SURGICAL APPROACH, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL CONVENTIONAL HIP SCREWS MARKET SIZE, BY MINIMALLY INVASIVE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL CONVENTIONAL HIP SCREWS MARKET SIZE, BY MINIMALLY INVASIVE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL CONVENTIONAL HIP SCREWS MARKET SIZE, BY MINIMALLY INVASIVE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL CONVENTIONAL HIP SCREWS MARKET SIZE, BY OPEN, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL CONVENTIONAL HIP SCREWS MARKET SIZE, BY OPEN, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL CONVENTIONAL HIP SCREWS MARKET SIZE, BY OPEN, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL CONVENTIONAL HIP SCREWS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL CONVENTIONAL HIP SCREWS MARKET SIZE, BY RECONSTRUCTIVE SURGERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL CONVENTIONAL HIP SCREWS MARKET SIZE, BY RECONSTRUCTIVE SURGERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL CONVENTIONAL HIP SCREWS MARKET SIZE, BY RECONSTRUCTIVE SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL CONVENTIONAL HIP SCREWS MARKET SIZE, BY TRAUMA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL CONVENTIONAL HIP SCREWS MARKET SIZE, BY TRAUMA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL CONVENTIONAL HIP SCREWS MARKET SIZE, BY TRAUMA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL CONVENTIONAL HIP SCREWS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL CONVENTIONAL HIP SCREWS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL CONVENTIONAL HIP SCREWS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL CONVENTIONAL HIP SCREWS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL CONVENTIONAL HIP SCREWS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL CONVENTIONAL HIP SCREWS MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL CONVENTIONAL HIP SCREWS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL CONVENTIONAL HIP SCREWS MARKET SIZE, BY ORTHOPEDIC CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL CONVENTIONAL HIP SCREWS MARKET SIZE, BY ORTHOPEDIC CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL CONVENTIONAL HIP SCREWS MARKET SIZE, BY ORTHOPEDIC CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL CONVENTIONAL HIP SCREWS MARKET SIZE, BY TRAUMA CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL CONVENTIONAL HIP SCREWS MARKET SIZE, BY TRAUMA CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL CONVENTIONAL HIP SCREWS MARKET SIZE, BY TRAUMA CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL CONVENTIONAL HIP SCREWS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL CONVENTIONAL HIP SCREWS MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL CONVENTIONAL HIP SCREWS MARKET SIZE, BY DIRECT SALES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL CONVENTIONAL HIP SCREWS MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL CONVENTIONAL HIP SCREWS MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL CONVENTIONAL HIP SCREWS MARKET SIZE, BY DISTRIBUTORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL CONVENTIONAL HIP SCREWS MARKET SIZE, BY DISTRIBUTORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL CONVENTIONAL HIP SCREWS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. AMERICAS CONVENTIONAL HIP SCREWS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 61. AMERICAS CONVENTIONAL HIP SCREWS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 62. AMERICAS CONVENTIONAL HIP SCREWS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 63. AMERICAS CONVENTIONAL HIP SCREWS MARKET SIZE, BY SURGICAL APPROACH, 2018-2032 (USD MILLION)
  • TABLE 64. AMERICAS CONVENTIONAL HIP SCREWS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 65. AMERICAS CONVENTIONAL HIP SCREWS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 66. AMERICAS CONVENTIONAL HIP SCREWS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 67. NORTH AMERICA CONVENTIONAL HIP SCREWS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 68. NORTH AMERICA CONVENTIONAL HIP SCREWS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 69. NORTH AMERICA CONVENTIONAL HIP SCREWS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 70. NORTH AMERICA CONVENTIONAL HIP SCREWS MARKET SIZE, BY SURGICAL APPROACH, 2018-2032 (USD MILLION)
  • TABLE 71. NORTH AMERICA CONVENTIONAL HIP SCREWS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 72. NORTH AMERICA CONVENTIONAL HIP SCREWS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 73. NORTH AMERICA CONVENTIONAL HIP SCREWS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 74. LATIN AMERICA CONVENTIONAL HIP SCREWS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. LATIN AMERICA CONVENTIONAL HIP SCREWS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 76. LATIN AMERICA CONVENTIONAL HIP SCREWS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 77. LATIN AMERICA CONVENTIONAL HIP SCREWS MARKET SIZE, BY SURGICAL APPROACH, 2018-2032 (USD MILLION)
  • TABLE 78. LATIN AMERICA CONVENTIONAL HIP SCREWS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 79. LATIN AMERICA CONVENTIONAL HIP SCREWS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 80. LATIN AMERICA CONVENTIONAL HIP SCREWS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 81. EUROPE, MIDDLE EAST & AFRICA CONVENTIONAL HIP SCREWS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 82. EUROPE, MIDDLE EAST & AFRICA CONVENTIONAL HIP SCREWS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 83. EUROPE, MIDDLE EAST & AFRICA CONVENTIONAL HIP SCREWS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 84. EUROPE, MIDDLE EAST & AFRICA CONVENTIONAL HIP SCREWS MARKET SIZE, BY SURGICAL APPROACH, 2018-2032 (USD MILLION)
  • TABLE 85. EUROPE, MIDDLE EAST & AFRICA CONVENTIONAL HIP SCREWS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 86. EUROPE, MIDDLE EAST & AFRICA CONVENTIONAL HIP SCREWS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 87. EUROPE, MIDDLE EAST & AFRICA CONVENTIONAL HIP SCREWS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 88. EUROPE CONVENTIONAL HIP SCREWS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 89. EUROPE CONVENTIONAL HIP SCREWS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 90. EUROPE CONVENTIONAL HIP SCREWS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 91. EUROPE CONVENTIONAL HIP SCREWS MARKET SIZE, BY SURGICAL APPROACH, 2018-2032 (USD MILLION)
  • TABLE 92. EUROPE CONVENTIONAL HIP SCREWS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 93. EUROPE CONVENTIONAL HIP SCREWS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 94. EUROPE CONVENTIONAL HIP SCREWS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 95. MIDDLE EAST CONVENTIONAL HIP SCREWS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 96. MIDDLE EAST CONVENTIONAL HIP SCREWS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 97. MIDDLE EAST CONVENTIONAL HIP SCREWS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 98. MIDDLE EAST CONVENTIONAL HIP SCREWS MARKET SIZE, BY SURGICAL APPROACH, 2018-2032 (USD MILLION)
  • TABLE 99. MIDDLE EAST CONVENTIONAL HIP SCREWS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 100. MIDDLE EAST CONVENTIONAL HIP SCREWS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 101. MIDDLE EAST CONVENTIONAL HIP SCREWS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 102. AFRICA CONVENTIONAL HIP SCREWS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 103. AFRICA CONVENTIONAL HIP SCREWS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 104. AFRICA CONVENTIONAL HIP SCREWS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 105. AFRICA CONVENTIONAL HIP SCREWS MARKET SIZE, BY SURGICAL APPROACH, 2018-2032 (USD MILLION)
  • TABLE 106. AFRICA CONVENTIONAL HIP SCREWS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 107. AFRICA CONVENTIONAL HIP SCREWS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 108. AFRICA CONVENTIONAL HIP SCREWS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 109. ASIA-PACIFIC CONVENTIONAL HIP SCREWS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 110. ASIA-PACIFIC CONVENTIONAL HIP SCREWS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 111. ASIA-PACIFIC CONVENTIONAL HIP SCREWS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 112. ASIA-PACIFIC CONVENTIONAL HIP SCREWS MARKET SIZE, BY SURGICAL APPROACH, 2018-2032 (USD MILLION)
  • TABLE 113. ASIA-PACIFIC CONVENTIONAL HIP SCREWS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 114. ASIA-PACIFIC CONVENTIONAL HIP SCREWS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 115. ASIA-PACIFIC CONVENTIONAL HIP SCREWS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL CONVENTIONAL HIP SCREWS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 117. ASEAN CONVENTIONAL HIP SCREWS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 118. ASEAN CONVENTIONAL HIP SCREWS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 119. ASEAN CONVENTIONAL HIP SCREWS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 120. ASEAN CONVENTIONAL HIP SCREWS MARKET SIZE, BY SURGICAL APPROACH, 2018-2032 (USD MILLION)
  • TABLE 121. ASEAN CONVENTIONAL HIP SCREWS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 122. ASEAN CONVENTIONAL HIP SCREWS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 123. ASEAN CONVENTIONAL HIP SCREWS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 124. GCC CONVENTIONAL HIP SCREWS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 125. GCC CONVENTIONAL HIP SCREWS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 126. GCC CONVENTIONAL HIP SCREWS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 127. GCC CONVENTIONAL HIP SCREWS MARKET SIZE, BY SURGICAL APPROACH, 2018-2032 (USD MILLION)
  • TABLE 128. GCC CONVENTIONAL HIP SCREWS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 129. GCC CONVENTIONAL HIP SCREWS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 130. GCC CONVENTIONAL HIP SCREWS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 131. EUROPEAN UNION CONVENTIONAL HIP SCREWS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 132. EUROPEAN UNION CONVENTIONAL HIP SCREWS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 133. EUROPEAN UNION CONVENTIONAL HIP SCREWS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 134. EUROPEAN UNION CONVENTIONAL HIP SCREWS MARKET SIZE, BY SURGICAL APPROACH, 2018-2032 (USD MILLION)
  • TABLE 135. EUROPEAN UNION CONVENTIONAL HIP SCREWS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 136. EUROPEAN UNION CONVENTIONAL HIP SCREWS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 137. EUROPEAN UNION CONVENTIONAL HIP SCREWS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 138. BRICS CONVENTIONAL HIP SCREWS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 139. BRICS CONVENTIONAL HIP SCREWS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 140. BRICS CONVENTIONAL HIP SCREWS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 141. BRICS CONVENTIONAL HIP SCREWS MARKET SIZE, BY SURGICAL APPROACH, 2018-2032 (USD MILLION)
  • TABLE 142. BRICS CONVENTIONAL HIP SCREWS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 143. BRICS CONVENTIONAL HIP SCREWS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 144. BRICS CONVENTIONAL HIP SCREWS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 145. G7 CONVENTIONAL HIP SCREWS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 146. G7 CONVENTIONAL HIP SCREWS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 147. G7 CONVENTIONAL HIP SCREWS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 148. G7 CONVENTIONAL HIP SCREWS MARKET SIZE, BY SURGICAL APPROACH, 2018-2032 (USD MILLION)
  • TABLE 149. G7 CONVENTIONAL HIP SCREWS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 150. G7 CONVENTIONAL HIP SCREWS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 151. G7 CONVENTIONAL HIP SCREWS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 152. NATO CONVENTIONAL HIP SCREWS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 153. NATO CONVENTIONAL HIP SCREWS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 154. NATO CONVENTIONAL HIP SCREWS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 155. NATO CONVENTIONAL HIP SCREWS MARKET SIZE, BY SURGICAL APPROACH, 2018-2032 (USD MILLION)
  • TABLE 156. NATO CONVENTIONAL HIP SCREWS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 157. NATO CONVENTIONAL HIP SCREWS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 158. NATO CONVENTIONAL HIP SCREWS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 159. GLOBAL CONVENTIONAL HIP SCREWS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 160. UNITED STATES CONVENTIONAL HIP SCREWS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 161. UNITED STATES CONVENTIONAL HIP SCREWS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 162. UNITED STATES CONVENTIONAL HIP SCREWS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 163. UNITED STATES CONVENTIONAL HIP SCREWS MARKET SIZE, BY SURGICAL APPROACH, 2018-2032 (USD MILLION)
  • TABLE 164. UNITED STATES CONVENTIONAL HIP SCREWS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 165. UNITED STATES CONVENTIONAL HIP SCREWS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 166. UNITED STATES CONVENTIONAL HIP SCREWS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 167. CHINA CONVENTIONAL HIP SCREWS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 168. CHINA CONVENTIONAL HIP SCREWS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 169. CHINA CONVENTIONAL HIP SCREWS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 170. CHINA CONVENTIONAL HIP SCREWS MARKET SIZE, BY SURGICAL APPROACH, 2018-2032 (USD MILLION)
  • TABLE 171. CHINA CONVENTIONAL HIP SCREWS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 172. CHINA CONVENTIONAL HIP SCREWS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 173. CHINA CONVENTIONAL HIP SCREWS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)